State of Tennessee, Department of Treasury’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,230
Closed -$83.1K 1708
2023
Q3
$83.1K Sell
19,230
-17,785
-48% -$98.8K ﹤0.01% 1576
2023
Q2
$244K Buy
37,015
+3,559
+11% +$22.8K ﹤0.01% 1569
2023
Q1
$227K Sell
33,456
-6,062
-15% -$42.6K ﹤0.01% 1517
2022
Q4
$292K Buy
39,518
+474
+1% +$4.62K ﹤0.01% 1466
2022
Q3
$386K Buy
39,044
+2,404
+7% +$25.4K ﹤0.01% 1389
2022
Q2
$399K Sell
36,640
-315
-0.9% -$3.26K ﹤0.01% 1394
2022
Q1
$418K Buy
36,955
+4,442
+14% +$58.4K ﹤0.01% 1449
2021
Q4
$510K Buy
32,513
+1,600
+5% +$27.9K ﹤0.01% 1360
2021
Q3
$531K Sell
30,913
-1,884
-6% -$33K ﹤0.01% 1351
2021
Q2
$706K Sell
32,797
-322
-1% -$5.76K ﹤0.01% 1267
2021
Q1
$498K Buy
33,119
+112
+0.3% +$1.81K ﹤0.01% 1327
2020
Q4
$433K Buy
33,007
+858
+3% +$10.3K ﹤0.01% 1306
2020
Q3
$311K Buy
32,149
+750
+2% +$8.02K ﹤0.01% 1304
2020
Q2
$359K Sell
31,399
-2,528
-7% -$28.6K ﹤0.01% 1250
2020
Q1
$352K Sell
33,927
-185
-0.5% -$2.29K ﹤0.01% 1223
2019
Q4
$560K Sell
34,112
-5,280
-13% -$79.8K ﹤0.01% 1231
2019
Q3
$523K Buy
39,392
+3,215
+9% +$44.8K ﹤0.01% 1264
2019
Q2
$510K Sell
36,177
-362
-1% -$5.76K ﹤0.01% 1217
2019
Q1
$672K Buy
36,539
+499
+1% +$11.4K ﹤0.01% 1150
2018
Q4
$942K Buy
+36,040
New +$847K 0.01% 1017

Other funds holding VNDA

State of Tennessee, Department of Treasury's VNDA Position: Q4 2023 in Review

State of Tennessee, Department of Treasury sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 19,230 shares — an estimated $83.1K sold.

State of Tennessee, Department of Treasury first reported a position in VNDA in Q4 2018 and held it in 20 quarters. The position peaked at $942K in Q4 2018. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.

  • State of Tennessee, Department of Treasury reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 19,230 Vanda Pharmaceuticals shares in Q4 2023, an estimated $83.1K.
  • State of Tennessee, Department of Treasury first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 20 quarters.
  • State of Tennessee, Department of Treasury's Vanda Pharmaceuticals position peaked at $942K in Q4 2018.
  • 157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.

Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2023, filed 14 Feb 2024.